Literature DB >> 27426660

Metabolic surgery in patients over 60 years old: short- and long-term results.

Y Van Nieuwenhove1, E Spriet1, T Sablon1, E Van Daele1, W Willaert1, W Ceelen1, P Pattyn1.   

Abstract

PURPOSE: Laparoscopic Roux-en-Y gastric bypass can treat obesity related comorbidities and can prolong life expectancy. It remains unclear whether this type of surgery is also indicated in obese patients with advanced age.
MATERIALS AND METHODS: In this retrospective monocentric study, we investigated the morbidity and outcomes of weight and metabolic control of bariatric surgery in patients older than 60 years and compared these findings with those of younger patients.
RESULTS: At 18 months after RY gastric bypass, weight losses of respectively 30 ± 11% and 34 ± 9% of total initial body weight were measured in the older and younger patients (p < 0.05). After 12 months, HbA1c dropped below 6.5% in 89% of patients younger and in 81% of patients older than 60 (p = 0.11). There was no mortality in either group, but there were significantly more complications and there was a longer hospital stay in the older patients.
CONCLUSION: RY gastric bypass comes with a significantly higher morbidity and hospital stay in older patients, but weight loss and improvement of DM are similar as in the younger patients.

Entities:  

Keywords:  Bariatric; diabetes; elderly patients; gastric bypass; metabolic; morbidity

Mesh:

Year:  2016        PMID: 27426660     DOI: 10.1080/00015458.2016.1181323

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  2 in total

Review 1.  Is Laparoscopic Bariatric Surgery Safe and Effective in Patients over 60 Years of Age?" an Updated Systematic Review and Meta-Analysis.

Authors:  Antoine Vallois; Benjamin Menahem; Arnaud Alves
Journal:  Obes Surg       Date:  2020-10-08       Impact factor: 4.129

2.  Effectiveness and Safety of Roux-en-Y Gastric Bypass in Elderly Patients-Systematic Review and Meta-analysis.

Authors:  Paweł Marczuk; Michał J Kubisa; Michał Święch; Maciej Walędziak; Piotr Kowalewski; Piotr Major; Michał Pędziwiatr; Krzysztof Paśnik; Michał R Janik
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.